|
Item
1.01
|
Entry
Into A Material definitive Agreement.
|
On December 14, 2018, a wholly-owned
subsidiary of Bionik Laboratories Corp. (the “Company”) entered into a Sale of Goods Agreement (the
“Agreement”) with CHC Management Services, LLC (“Kindred”), dated as of December 13, 2018, pursuant
to which, among other things, Kindred agreed to purchase from the Company in a first phase a minimum of 21 of
the Company’s InMotion ARM Interactive Therapy Systems – a minimum of one for each of Kindred’s existing
and soon-to-open affiliated inpatient rehabilitation hospitals and similar facilities described in the Agreement and in a second phase a minimum of one InMotion ARM Interactive Therapy System for each
future facilities of Kindred, during the four-year minimum term of the Agreement.
The purchase price per unit is based on
the purchase order and delivery date of the unit, as described in the Agreement. The Company expects that Kindred will enter into
an initial purchase order for eight units of the InMotion ARM Interactive Therapy System for shipment on or before December 31,
2018, at the purchase price described in the Agreement.
The Agreement is subject to reasonably
customary terms regarding shipment and delivery, early termination, and warranties and liability, among other matters.
The foregoing is a brief description of
the terms of the Agreement and is qualified in its entirety by reference to the full text of the Agreement, a copy of which is
included as Exhibit 10.1 to this Current Report on Form 8-K, which is incorporated herein by reference.
Forward-Looking Statements
Statements contained in this Current Report
on Form 8-K relating to the Company’s intentions, hopes, beliefs, expectations or predictions of the future, including statements
relating to the Company’s results of operations and financial results and any other statements about the Company’s
future expectations, beliefs, goals, plans or prospects, are forward-looking statements. The Company’s actual results could
differ materially from those projected in these forward-looking statements. These forward-looking statements are made on the basis
of the current beliefs, expectations, and assumptions of management, are not guarantees of performance and are subject to significant
risks and uncertainty. These forward-looking statements should, therefore, be considered in light of various important factors,
including those set forth in the Company’s periodic reports filed from time to time with the Securities and Exchange Commission.
You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this Current
Report on Form 8-K. The Company disclaims any obligation to publicly update or release any revisions to these forward-looking statements,
whether as a result of new information, future events or otherwise, after the date of this Current Report on Form 8-K or to reflect
the occurrence of unanticipated events, except as required by law.